Clinical Trials · NCT04158362
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- UNICANCER
- Enrollment
- 180
- Start date
- Jun 2020
- Locations
- 2 sites, France
- Primary endpoint
- Progression-free survival (PFS)